Device Transactions Medtech fundraising totaled $714 million in 2014’s opening quarter, a significant decrease – just over 40% – from Q4 2013’s $1.2 billion. ( See Exhibit 1. ) Exhibit 1 Q1 2014 Devic
IN VITRO DIAGNOSTICS Arno Therapeutics Inc. University of Minnesota Arno exclusively licenses Univ. of MN 's gene expression signature technique Arno Therapeutics Inc. (oncology) licensed exc
IN VITRO DIAGNOSTICS Assistance Publique-Hopitaux de Paris Centre National de la Recherche Scientifique French National Institute for Health (INSERM) IntegraGen SA Paris Descartes University Integra